PLA2R1 and Autoimmunity: Personalized treatment on the initial pathological causes leading to the autoimmunity to PLA2R or THSD7A is not yet feasible, as our understanding on the upstream and downstream events contributing to PLA2R- and THSD7A-associated MN remain limited.